Eidos Therapeutics
Why Robinhood?
You can watch EIDX and buy or sell other stocks, ETFs, and their options commission-free!About EIDX
Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR.
EIDX Key Statistics
Stock Snapshot
Eidos Therapeutics(EIDX) stock is priced at $122.21, giving the company a market capitalization of 4.75B. It carries a P/E multiple of -46.10.
On 2026-04-01, Eidos Therapeutics(EIDX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 138.46K.
Over the past 52 weeks, Eidos Therapeutics(EIDX) stock has traded between a high of $132.54 and a low of $28.39.
Over the past 52 weeks, Eidos Therapeutics(EIDX) stock has traded between a high of $132.54 and a low of $28.39.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.